Guideline | Drug Name |
---|---|
Dichlorphenamide Agents | Keveyis (dichlorphenamide), Ormalvi (dichlorphenamide) |
Dojolvi (triheptanoin) | Dojolvi (triheptanoin) |
Doptelet (avatrombopag) | Doptelet (avatrombopag) |
DPP-4 Inhibitors - ST, NF | Janumet (sitagliptin/metformin), Janumet XR (sitagliptin/metformin extended-release), Zituvimet (sitagliptin/metformin), Zituvimet XR (sitagliptin/metformin), Januvia (sitagliptin), Jentadueto (linagliptin/metformin), Jentadueto XR (linagliptin/metformin extended-release), Kazano (alogliptin/metformin), Kombiglyze XR (saxagliptin/metformin), Nesina (alogliptin), Onglyza (saxagliptin), Oseni (alogliptin/pioglitazone), Tradjenta (linagliptin), Zituvio (sitagliptin) |
Duexis (ibuprofen and famotidine) - PA, NF | Duexis (ibuprofen/famotidine) |
Duobrii (halobetasol propionate and tazarotene) - PA, NF | Duobrii (halobetasol propionate and tazarotene) |
Dupixent (dupilumab) | Dupixent (dupilumab) |
Duvyzat (givinostat) | Duvyzat (givinostat) |
Dysport (abobotulinumtoxinA) | Dysport (abobotulinumtoxinA) |
Ebglyss (lebrikizumab-lbkz) | Ebglyss (lebrikizumab-lbkz) |
Egrifta (tesamorelin) | Egrifta SV (tesamorelin) |
Elaprase (idursulfase) | Elaprase (idursulfase) [1] |
Elevidys (delandistrogene moxeparvovec-rokl) - PA, NF | Elevidys (delandistrogene moxeparvovec-rokl) |
Elmiron (pentosan polysulfate sodium) | Elmiron (pentosan polysulfate sodium) |
Elyxyb (celecoxib) Oral Solution - PA, NF | Elyxyb (celecoxib) Oral Solution |
Emergency Agents for the Treatment of Severe Hypoglycemia - ST, NF | Glucagen, Glucagon, Gvoke |
Emflaza (deflazacort) - PA, NF | Emflaza (deflazacort) |
Empaveli (pegcetacoplan) | Empaveli (pegcetacoplan) |
Enbrel (etanercept) | Enbrel (etanercept) |
Endari (L-glutamine oral powder) | Endari (L-glutamine) |